Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Regeneron Pharmaceuticals REGN Stock Holding History

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$873K	Hold	1,400	–	–	0.35%	77
2026 Q1	$1.08M	Hold	1,400	–	–	0.56%	59
2025 Q4	$1.08M	Hold	1,400	–	–	0.53%	60
2025 Q3	$787K	Hold	1,400	–	–	0.42%	67
2025 Q2	$735K	Hold	1,400	–	–	0.38%	71
2025 Q1	$888K	Sell	1,400 -1	-0.1%	-$688	0.56%	57
2024 Q4	$998K	Buy	1,401 +304	+28%	+$255K	0.58%	59
2024 Q3	$1.15M	Sell	1,097 -50	-4%	-$55.6K	0.73%	50
2024 Q2	$1.21M	Sell	1,147 -50	-4%	-$48.5K	0.78%	43
2024 Q1	$1.15M	Sell	1,197 -50	-4%	-$47.5K	0.79%	46
2023 Q4	$1.1M	Hold	1,247	–	–	0.91%	36
2023 Q3	$1.1M	Buy	1,247 +147	+13%	+$116K	0.91%	36
2023 Q2	$790K	Buy	1,100 +150	+16%	+$116K	0.69%	45
2023 Q1	$781K	Hold	950	–	–	0.8%	38
2022 Q4	$685K	Sell	950 -150	-14%	-$111K	0.97%	34
2022 Q3	$758K	Buy	1,100 +200	+22%	+$126K	1.28%	23
2022 Q2	$532K	Sell	900 -150	-14%	-$97.5K	0.82%	39
2022 Q1	$733K	Buy	+1,050	New	+$664K	0.84%	40

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s REGN Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 1,400 shares worth $873K. The position accounts for 0.35% of the portfolio, ranked #77.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in REGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.21M in Q2 2024. 1,004 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 1,400 shares of Regeneron Pharmaceuticals worth $873K as of Q2 2026.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.35% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #77 holding.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Regeneron Pharmaceuticals position peaked at $1.21M in Q2 2024.
1,004 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.